Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study

To compare the efficacy and safety of remimazolam besylate and propofol for deep sedation in critically ill patients.

Source: Critical Care - December 4, 2023 Category: Intensive Care Authors: Yun Tang, Xuehui Gao, Jiqian Xu, Lehao Ren, Hong Qi, Ruiting Li, Huaqing Shu, Xiaojing Zou, Shiying Yuan, Xiaobo Yang and You Shang Tags: Brief Report Source Type: research